New Targets and New Drugs for Cancer Treatment - New Small-Structure Drugs Approved by the FDA from 2020 to 2025 New Small-Structure Drugs Approved by the FDA from 2020 to 2025

Precision medicine has faced significant advances recently. However, cancer remains a major concern in contemporary societies. The development of new therapeutic strategies for cancer treatment remains an unmet clinical need. This book offers a comprehensive analysis of oncological pharmacology. Focusing on the period between 2020 and 2025, this book serves as a reference for medicinal chemists, pharmacologists, and clinicians. Readers will find synonyms, IUPAC nomenclature, FDA approval year, indication, mechanism of action, and patent-reported synthesis for every compound shown in the work. Sprache: Englisch Gewicht in Gramm: 368.